Provided by Tiger Fintech (Singapore) Pte. Ltd.

MDxHealth, Inc.

3.53
-0.0600-1.67%
Post-market: 3.570.0400+1.13%16:56 EDT
Volume:179.26K
Turnover:631.52K
Market Cap:174.73M
PE:-4.51
High:3.58
Open:3.57
Low:3.45
Close:3.59
52wk High:3.81
52wk Low:1.35
Shares:49.50M
Float Shares:35.02M
Volume Ratio:0.88
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7820
EPS(LYR):-1.1585
ROE:-1552.23%
ROA:-7.92%
PB:-197.88
PE(LYR):-3.05

Loading ...

MDxHealth Reports Strong Revenue Growth in 2025 Interim Results

TIPRANKS
·
Aug 15

MDxHealth SA reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 14

MDxHealth SA expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
Aug 12

Bio-Techne beats quarterly estimates, flags tariff uncertainty for customers

Reuters
·
Aug 07

MDxHealth (MDXH) Receives a Buy from BTIG

TIPRANKS
·
Aug 06

MDxHealth’s Strategic Acquisition and Financial Growth Drive Buy Rating

TIPRANKS
·
Aug 06

Bio-Techne beats quarterly estimates on strength in protein sciences unit

Reuters
·
Aug 06

MDxHealth Announces Q2 Results and Strategic Acquisition of Exosome Diagnostics

TIPRANKS
·
Aug 06

Bio-Techne Corporation Announces Divestiture of Exosome Diagnostics to Mdxhealth in Strategic Move

Reuters
·
Aug 06

MDxHealth Reports 20% Increase in Q2 Revenue, Achieves Positive Adjusted EBITDA of $1.4 Million, and Reduces Net Loss by 36%

Reuters
·
Aug 06

MDxHealth Sa - Qtrly Prelim Net Loss per Share $0.15

THOMSON REUTERS
·
Aug 06

MDxHealth Sa - Agreement to Buy Exodx Business for $15 Mln

THOMSON REUTERS
·
Aug 06

MDxHealth Sa - Q2 Revenues $26.6 Mln

THOMSON REUTERS
·
Aug 06

MDxHealth Sa - Announces Acquisition of Exosome Diagnostics

THOMSON REUTERS
·
Aug 06

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne

GlobeNewswire
·
Aug 06

MDxHealth CFO Kalfus Resigns

Dow Jones
·
Jul 04

Press Release: Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change

Dow Jones
·
Jul 04

MDxHealth Schedules Second EGM for Share Option Plan Approval

TIPRANKS
·
Jun 07

MDxHealth’s Strong Performance and Undervalued Growth Potential Justify Buy Rating

TIPRANKS
·
May 15

MDxHealth’s Strong Financial Performance and Growth Prospects Justify Buy Rating

TIPRANKS
·
May 15